Latest news
Loading news…
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Vividion Therapeutics was acquired by Bayer in 2021 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Investments
1
1 exits
Monthly Visits
Available in Pro Contacts
206
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 60
- Active products
- 18
- IT spend
- $3M
Investor Activity
- Investments
- 1
- Lead investments
- 1
- Portfolio orgs
- 1
- Exits
- 1
Company Info
- Org types
- company, investor
- HQ
- San Diego, California, United States
Signals & Scores
- Trend (7d)
- -0.4
- Trend (30d)
- 3.4
- Trend (90d)
- 3.5
Investments by Vividion Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Vividion Therapeutics
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Vividion Therapeutics
Chief Financial Officer
Executive Chairman
Senior Vice President of Operations and Alliances
Founder
206
professional contacts at Vividion Therapeutics
Contact execs at Vividion Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Vividion Therapeutics
Loading news…
FAQs about Vividion Therapeutics
People who checked this page also checked these
Sectors Vividion Therapeutics invests & acquires in
Browse the full Acquirezy directory.